Association between C-reactive protein and age-related macular degeneration

Mitali Borooah; Jayant Ekka

doi:10.18203/2320-6012.ijrms20191329

Authors

Mitali Borooah Department of Ophthalmology, Assam Medical College and Hospital, Dibrugarh, Assam, India
Jayant Ekka Department of Ophthalmology, Assam Medical College and Hospital, Dibrugarh, Assam, India http://orcid.org/0000-0003-1466-2630

DOI:

https://doi.org/10.18203/2320-6012.ijrms20191329

Keywords:

Age-related macular degeneration (AMD), C-reactive protein, Choroidal neovascular membrane, Drusen, Geographical atrophy, hsCRP

Abstract

Background: Age-related macular degeneration (AMD) is the leading cause of irreversible visual impairment among the elderly, worldwide affecting 30-50 million individuals. Inflammation is now increasingly thought to be a key risk factor for AMD. The association of CRP with AMD has been reported in only a few studies, with somewhat inconsistent results. The present study was undertaken to determine the association between AMD and serum CRP levels.

Methods: A total of 53 patients diagnosed of any form of AMD fulfilling inclusion and exclusion criteria were included. A 5 mL sample of venous blood (non-fasting) was collected to determine serum high-sensitivity CRP levels (hsCRP). Different stages of AMD and serum hs CRP level were compared using one-way ANOVA test and calculated p value <0.05 was considered as statistically significant. Comparison between the two groups, one with risk factor and one without risk factor was performed using student-t test and calculated p value <0.05 was considered statistically significant.

Results: Out of 53 patients 21 were having early AMD, 21 were having intermediate AMD and 11 were having advanced AMD. The mean serum hs CRP level was 0.14±0.05 mg/dL, 0.20±0.09 mg/dL and 0.28±0.08 mg/dL in early, intermediate and advanced AMD respectively. When statistically analysed the difference of mean serum hs CRP level among the three groups was found to be statistically significant.

Conclusions: Type of AMD influence the baseline hsCRP level. Smoking and diabetes are associated with higher baseline serum hsCRP in all stages of AMD.

Metrics

Metrics Loading ...

References

Resnikoff S, Pascolini D, Etya'Ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bulletin World Health Organization. 2004;82:844-51.

Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Survey Ophthalmol. 1995;39(5):367-4.

Friedman DS, O’Colmain BJ, Munoz B, Tomany SC, McCarty C, De Jong PT, et al. Prevalence of age-related macular degeneration in the United States. Arch ophthalmol. 2004;122(4):564-72.

Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol. 2004;137(3):486-95.

Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age related macular degeneration. New Eng J Med. 2006;355(14):1419-31.

World Health Organization. Age related macular degeneration: priority eye diseases. Accessed at: http://www.who.int/blindness/causes/priority/en/index8.html.

Age-related eye disease study research group. The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the age-related eye disease study report number 6. Am J Ophthalmol. 2001;132(5):668-81.

Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA. 2004;291(6):704-10.

McGwin G, Hall TA, Xie A, Owsley C. The relation between C reactive protein and age-related macular degeneration in the Cardiovascular Health Study. British J Ophthalmol. 2005;89(9):1166-70.

Schaumberg DA, Christen WG, Buring JE, Glynn RJ, Rifai N, Ridker PM. High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women. Archives Ophthalmol. 2007;125(3):300-5.

Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today. 1994;15(2):81-8.

Boekhoorn SS, Vingerling JR, Witteman JC, Hofman A, de Jong PT. C-reactive protein level and risk of aging macula disorder: The Rotterdam Study. Archives Ophthalmol. 2007;125(10):1396-401.

Čolak E, Kosanović-Jaković N, Žorić L, Radosavljević A, Stanković S, Majkić-Singh N. The association of lipoprotein parameters and C-reactive protein in patients with age-related macular degeneration. Ophthalmic Res. 2011;46(3):125-32.

Boey PY, Tay WT, Lamoureux E, Tai ES, Mitchell P, Wang JJ, et al. C-reactive protein and age-related macular degeneration and cataract: the Singapore Malay Eye Study. Inv Ophthalmol Visual Sci. 2010;51(4):1880-5.

Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: a review of association. Eye. 2005;19(9):935.

McCarty CA, Mukesh BN, Fu CL, Mitchell P, Wang JJ, Taylor HR. Risk factors for age-related maculopathy: the visual impairment project. Archives Ophthalmol. 2001;119(10):1455-62.

Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: The beaver dam eye study. Ophthalmol. 2002;109(10):1767-9.

Vingerling JR, Hofman A, Grobbee DE, De Jong PT. Age-related macular degeneration and smoking: the Rotterdam Study. Archives Ophthalmol. 1996;114(10):1193-6.

Khan JC, Thurlby DA, Shahid H, Clayton DG, Yates JR, Bradley M, et al. Smoking and age-related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. British J Ophthalmol. 2006;90(1):75-80.

Christen WG, Glynn RJ, Manson JE, Ajani UA, Buring JE. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA. 1996;276(14):1147-51.

Wilson GA, Field AP, Wilson N. Smoke gets in your eyes: smoking and visual impairment in New Zealand. New Zealand Med J. 2001;114(1142):471.

Snow KK, Seddon JM. Do age-related macular degeneration and cardiovascular disease share common antecedents?. Ophthalmic Epidemiol. 1999;6(2):125-43.

Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285(19):2481-5.

Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363-9.